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Alveolarmacrophages (AM)storearachidonicacid(AA), whichisesterified incelularphospholipidsuntil liberated
byphospholipaseA2 orCafterexposuretoinflammatory stimuli. Afterrelease, therecanbesubsequentmetabolismof
AAinto various potent, biologicaflyactivemediators including prostlandinsand platelt-activating factor(PAF). To
examinethepossibilitythatthesemediatorsmay accountfor someofthepathophysiologicalterations seeninthelungafter
ozone(03) exposure, humanAM werecoOlectedbybronchoalveolar lavageofnormal subjects, platedidotissueculture
dishes, andtheadherentcells wereincubated with A or [3H]lysoPAF. Human AMexposed to 1.0 ppm 03 for2 hr
released 65 ± 12% moretritium, derived from 13H]AA, than paired, air-exposed controls intomediasupernatants. In
otherstudiesusing asimilarO3exposure protocol, there wasalso a s nt increase inhumanAM aglandin E2
production (2.0 ± 0.5-fold increaseaboveair-exposurevalues,p < 0.01, n = 17). In additionalstudies, usngaslar03
exposure protocol (1.0 ppmfor 1 hr), therewasalso a si nt increaseinhuman AMPAFcontent (1.7 ± 0.2-fold in-
creaseaboveair-exposure values,p < 0.02, n = 5). Thesepotent lipid mediators, originally derived from human AM,
may play animportant role in the mechanisms of03 lungtoxicity.
Introduction
Ozone(03) is amajorphotochemical airpollutantthatcauses
deleterious health effects on inhalation (1). This oxidant gas,
formedbycomplex reactionsofnitrousoxideswith oxygen, can
be found at concentrations exceeding 0.3 ppm in several U.S.
areas, withambientlevelsgenerally around0.01-0.04 ppm. The
lung is the main site of 03-induced toxicity, although extra-
pulmonary effects have been reported. Altered lung function,
bronchial hyperresponsiveness, and a lung inflammatory re-
sponse(measured asthepresenceofneutrophilsandbiochemical
mediators of inflammation, e.g., AA metabolites, in bron-
choalveolarlavage) havebeen reported in humans after 03 ex-
posure (2-4).
Animportantresidentcellofthelungthat maybeaffectedby
ozoneisthealveolarmacrophage. Thesecells arethepredomi-
nant cell type within the alveolus and serve as the resident
mononuclearphagocytesofthelung. Alveolarmacrophagesplay
an important role in immune and inflammatory processes be-
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cause of the numerous mediators they secrete in response to
phagocytic or inflammatory stimuli (5,6). Therefore, alveolar
macrophagesserveasthefirstlineofhostdefenseagainstinhaled
organisms and soluble and particulate molecules. Ozone ex-
posurehasbeenshowntoadverselyaffecthostdefensemecha-
nism(s)ofanimalsagainstcertaininfectious agents. Inhalation
of03hasbeenreportedtoresultinasignificantincreaseinmor-
talityofmiceexposedtoaerosolsofinhaledmicroorganisms(7).
Ithasbeensuggestedthatthiseffectmaybeattributable, atleast
inpart, toperturbationsinpulmonaryalveolarmacrophageim-
munedefensemechanisms. Decreasedphagocytosis, decreased
superoxide anion production, decreased lysosomal enzyme
release, anddecreased interferon synthesishavebeenreported
foralveolarmacrophages aftereither in vivo or in vitro 03 ex-
posure (8-13). Thisobservedtoxicityof03toalveolarmacro-
phage functions may be due in part to the location ofalveolar
macrophages intheairway lumen, allowing greaterexposureto
03 comparedtoother lung cell types.
Metabolites ofthe membrane lipid constituents ofalveolar
macrophages represent an important class of macrophage
mediators. Alveolarmacrophagescanstoreandmetabolizethe
important lipid mediator arachidonic acid (AA). AA, a 20-
carbonfattyacid, isusuallyesterifiedincellularphospholipids
inmostcellMtsuntilliberatedbyphospholipaseA2orCactivi-
tyfrommembranephospholipids. Onceliberated,AAcanserve
asasourcefortheproductionofpotentlipidmediatorsincluding
cyclooxygenase and lipoxygenase products and platelet-acti-
vating factor(PAF).FRIEDMANETAL.
MetabolismofAAthroughcyclooxygenaseinitiallygenerates
theoxygenatedproductprostaglandinendoperoxidaseG2. This
endoperoxide is enzymatically converted to another cyclic en-
doperoxide, PGH2, by either cyclooxgenase activity or other
peroxidases. PGH2 can be furthermetabolized toprostacyclin
(PGI2) via prostacyclin synthetase activity; thromboxane
A2(TxA2) bythrmboxanesynthetasecatalysis; orotherprimary
prostaglandins (PG) through enzymatic and nonenzymatic
means (PGE2, PGF2,). Cyclooxygenase activitycanbe stimu-
latedbylowconcentrationsofeitherhydroperoxidesand/orlipid
peroxides (generally 1-10 ytM depending on the cell type),
whereashighconcentrations (usually 10-100AM)areinhibitory
toactivity. Inaddition, cyclooxygenase is a "suicide" enzyme,
i.e., the enzyme is inactivated after conversion ofa sufficient
amountofsubstrateintoproductmostprobablythroughforma-
tion ofan activeoxygen species.
ConversionoffreeAAbytheactionoflipoxygenases results
intheformationofunstablehydroperoxyeicosatetraenoic acids
(HPETEs), generally the 5-, 12-, or 15- isomers in most cell
types. These compounds are then metabolized either to their
hydroxy- or dihydroxy-acid forms, e.g.,15-HETE, or to
leukotrienes when 5-HPETE is converted to the unstable in-
termediateleukotrieneA4(LTA4). The5-lipoxygenasepathway
isamajorpathwayofAAmetabolisminalveolarmacrophages.
LTA4isconvertedeithertoLTB4byenzymatichydrolysisorto
thesulfidopeptide leukotrienes(L1C4, LTD4, LTE4)viathead-
dition and sequential cleavage ofglutathione viathe action of
glutathione-S-transferase, y-glutamyltranspeptidase, anddipep-
tidase. Theleukotrienes C4, D4, andE4, collectively knownas
"slow-reacting substanceofanaphylaxis" (SRS-A), causebron-
choconstriction via smooth muscle contraction and stimulate
mucus secretion either individually or inthe SRS-Acomplex.
LIC4 and LTD4 producecoughing and chest tightness in both
normal and asthmatic subjects. They also increase vascular
permeability. LTB4isapotentchemotactic agentforPMNsand
eosinophils andmayplaya role in therecruitmentofPMNs to
inflammatory foci in the lung. It is unclear at present whether
lipoxygenases are self-inactivated after metabolism of AA.
Unlikecyclooxygenase, lipoxygenasesarenotknowntopossess
the peroxidase activity for converting their hydroperoxy acid
metabolites tothe alcohol form.
PAF is synthesized and secreted in response to a variety of
stimuliinseveralcelltypes, particularlythosecells, suchasthe
alveolarmacrophage, thatareinvolvedininflammatoryandim-
mune functions. PAF has now been identified as 1-0-alkyl-
2-acetyl-sn-GPC (glycero-3-phosphocholine). Someofthebio-
actionsofPAFincludeplateletaggregation,degranulation,migra-
tion,andsuperoxideproductionbyPMN,andbronchoconstric-
tion. The immediate precursor ofPAF is lyso-PAF (in the
'sremodelingpathway," whichisgenerallybelievedtoberespon-
sibleforstimulus-mediatedPAFsynthesisthatoccursininflam-
matory cells such as the alveolarmacrophage), which appears
transientlyaftercellactivation. Lyso-PAFisderivedfrompreex-
istingcellularpoolsofl-0-alkyl-2-acyl-sn-GPC throughtheac-
tionofaphospholipaseA2(PLA2)toform1-0-alkyl-2-lyso-GPC,
whichinturnisacetylatedbyanacetyltransferasetoproducePAF
(1-0-alkyl-2-acetyl-GPC). ThisfirststepofPAFsynthesis, i.e.,
thecleavingofAAfromalkyl-arachidonyl-GPC,thusreleasestwo
importantprecursormolecules, AAandlyso-PAF.
Thus, there are severalpotential mechanisms forthe release
ofAA inalveolarmacrophages. Depending onthetype ofAA
release mechanism(s), anumberofpotentand importantlipid
mediatorsmaybeformed, whichcanplay animportant role in
theinflammatoryandphysiologicresponseofthelung. Wenow
reportthatexposureofhumanalveolarmacrophagesin vitroto
03 results insignificantchanges in alveolarmacrophage lipid
metabolism including release of AA, increased synthesis of
PGE2, and increased contentofPAF.
Materials and Methods
Reagents
CommonAmerican Chemical Society-grade chemicals and
reagents, HPLC-gradeoiganicsolvents,polypropyleneandglass
tubes, Whatmanpaper,pipettes, tissueculturedisposables, and
Scintinverse LC scintillation cocktail were purchased from
Fisher Scientific (Raleigh, NC). Biochemicals, including en-
zymesandenzymereagents,Tris,HBSS,bovineserumalbumin,
EGTA, formyl-methionyl-leucyl-phenylalanine (FMLP),
A23187, phospholipids, andplatelet-activatingfactor, TritonX
100, siliconizingreagent,andacidphosphatasereagentswereall
obtained from Sigma Chemical Company (St. Louis, MO).
[3HJAA was obtained from NEN Dupont (Boston, MA).
[14C]PAF and [3H]LysoPAF were purchased from Amersham
(ArlingtonHeights, IL).
OzoneExposureSystem
Cellscultureswereexposedtopredeterminedconcentrations
ofozoneorairin35-or60-mmtissueculturepolystyrenepetri
dishesusinganin vitroozonechambersystem(Fig. 1)andcon-
sisting oftwo plexiglass and stainless-steel chambers (15 L in
capacity) through which filtered room air at 37C, with or
without03, waspassedataflowrateof7.5 L/min. Separatein-
putlinescarriedhumidifiedaircontainingCO2 intothecham-
berstomaintaina5% CO2atmosphereasregulatedby2 CH/P
CO2Analyzers(FormaScientific, Marietta,OH). Thechambers
were mounted on rocking platforms (Bellco Glass, Vineland,
NJ), which permitted rocking of the petri dishes during ex-
posure. Chambers andplatforms were enclosed in 37C incu-
FIGURE 1. In vitro ozone exposure system. A, temperature-controlled in-
cubator; B, zero-gradeair; C, humidifier;D, ozonegenerator; E, plexiglass
and steelchamber; F, rockerplatform: G, condenser; H, ozoneanalyzer.
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bators(FormaScientific,Marietta, OH). Ozonewasgenerated
bypassingthehumidifiedairoveraUVlamp; thebrightnesswas
regulatedbypartiallycoveringthelampwithasteeltubeuntilthe
desired 03 concentration was reached. Ozone concentrations
were determined by sampling the chamber atmosphere,
dehumidifying it with a condenser, and passing the air into a
Model 1003-AHOzoneAnalyzer(Dasibi,Glendale, CA), which
wasperiodically calibratedby instrumentation traceable tothe
NationalBureauofStandards. Alllinesandfittingsinthesystem
were Teflon, glass, or stainless steel. The pH of phosphate-
buffered saline(PBS)orHank'sbufferedsaltsolutionwasfound
tobe unchanged after2 hrofexposure to 1.0ppm03.
Human Alveolar Macrophages
Healthy, nonsmoking male volunteers 18-35 years of age
underwentfiberopticbronchoscopy andbronchoalveolarlavage
toobtain normal human alveolarmacrophages foruse inthese
experiments. Eachsubjectwasremuneratedandsignedastate-
mentofconsentafterbeinginformedofthepurpose, procedure,
andrisksofthebronchoalveolarlavageprotocol. Theprocedure
wasapprovedbytheCommitteeontheRightsofHumanSubjects
ofthe University ofNorth Carolina School ofMedicine.
Beforebronchoscopy, allsubjectswerepremedicatedwith0.5
mg ofintravenous atropine. The posterior pharynx was anes-
thetizedbygargling witha4% lidocaine solutionin salineand
a lubricatingjelly containing 2% lidocaine was placed in the
nostril through which the bronchoscope (BF-1T1O, Olympus,
New Hyde Park, NY) was passed. Inaddition, some subjects
wereadministered 25-50mg ofDemorol intravenously. Lido-
caine was injectedthrough thebronchoscope atthelevel ofthe
vocal cords, thecarina, and more distal airway bifurcations to
decreasecoughing. Amaximumof20mLof2% lidocainewas
used. Forthelavage, thebronchoscopewaswedgedinasegmen-
talorsubsegmentalbronchusofthelingula, and50mLofsterile
salineatroomtemperaturewasslowlyinjectedthroughthebron-
choscope. The saline was immediately aspirated into a 50 mL
sterilepolypropylenetube, whichwasthenplacedonice. Atotal
ofsixwasheswereperformedforatotalof300mLofsalinein-
stilled. Thisprocedurewasthenrepeatedintherightmiddlelobe
with an additional 300 mLofsaline. Approximately 30 x 106
total viablealveolarmacrophages arerecoveredfromatypical
subject, witharecovery oftheinjectedsalineofapproximately
75%. Theviability oftherecoveredcellsexceeded85% bytry-
panblue exclusion.
Immediately aftertheprocedure, thelavage fluidcontaining
the cells wascentrifuged at350g for 10 min at4°C Cells were
thenpooledandwashedtwiceinRPMI-1640supplementedwith
0.025% gentamycin. Betweenthetwowashes, cellswerecounted
inahemocytometerandadjustedto 1 x 106viablemacrophages
per milliliter of RPMI 1640. Cell differentials were done on
cytocentrifuged slidespreparedat700rpmfor5minandstained
withamodifiedWrightstain (LeukostatSolution, FisherScien-
tific, Fairlawn, NJ). A typical differential countyielded 88%
alveolarmacrophages, 11% lymphocytes, and 1%polymorpho-
nuclearleukocytes.
Radiolabeling ofCells
Alveolar macrophages, in cultureflasks, wereradiolabeled
with 1 yiCi/mLofeither[3H]LysoPAFor[3H]AAfor30min-5
hr in RPMIwith 2% fetal calfserum. Afterlabeling, the cells
were washedthree times with PBS and then 1.5 mL PBS with
calcium, magnesium, andglucose(1 mg/mL)wasaddedandthe
cells were exposed to either air, 03, or the calcium ionophore
A23187 (10 sM). Approximately 70% of [3H]lysoPAF in the
medium wastaken upby the cells by30minofincubation and
50% ofthe[3H]AA wastakenupafter4hr.
ExtractionofCellularLipids
Reactionsandcellexposuresweretermiinatedbyscrapingthe
cellsfromthedisheswitharubberscraperandtransferringthem
toapolypropylenetubecontainingchloroform, rinsingthedish
with methanol, andpooling the rinsewith thechloroform/cell
mix. The proportions of solvents were always 0.8:1.0:2.0
aqueous:methanol:chloroform, asdescribedbyFolchetal. for
the extraction oflipids from tissues (23). In some cases, the
chloroformcontained afewhundreddisintegrationsperminute
of[14C]PAFasaninternalstndard. Aftermixing, thetubeswere
centrifuged at 500g for 2 min to separate the phases and the
chloroformphasewasremovedwithapasteurpipetteandplaced
itinasiliconizeddisposableglasstube. Asecondextractionwas
performed on the aqueous/methanol phase with an additional
two volumes ofchloroform, and the chloroform phases were
pooledandevaporatedina370Cheatingblockunderastreamof
N2. Theresultinglipidresiduewasredissolvedinasmallvolume
ofchloroform forHPLCorTLC.
Fgh-PerformanceLiquidChromatography
iWodifferentHPLCmethods wereemployed, onespecifically
designedfortheseparationofphospholipidsandanotherforthe
separationofAAmetabolites. Theinstrumentationusedwasthe
same for all methods and consisted oftwo Waters 510 HPLC
Pumps, a U6K manual injector, a System Interface Module, a
490EMultiwavelengthDetector, aNECAPCIVcomputer, and
the820Maximasoftwareprogram(WitersMillipore, Millford,
MA). Detection of radioactivity in the HPLC effluent was
monitored inaCRFlowONEBetaRadioactive Flow Detector
withaDIXData 1000computer(RadiomaticInstnuments,Tam-
pa, FL). ScintiverseLCliquidscintillationcocktailwasusedat
amixing ratioof3:1.
Phospholipid Separation
Theseparationmethodisdescribedingreaterdetailinanother
publication (14). The method uses two 25 cm x 4.8 mm
cyanopropylcolumns inseries, connectedwith a 10-cmlength
of0.010inofstainless-steeltubingandprotectedby anLC-CN
guard column cartridge. Themobilephase, solvents A and B,
consistedof100% acetonitrileand80% acetonitrile/20% 5mM
sodium acetate (pH 5.0), respectively, and were filtered and
degassedundervacuumbeforeuse. SolventBwasprepareddaily
topreventprecipitationofsalts. Themobilephaseandcolumns
were kept at60°C via acirculating water bath to facilitate the
separation of the acidic phospholipids and reduce the back
pressure inthe system. Agradient was usedata flow rateof2
mL/min, asfollows: from0to5.0min 10% B, from5.1 to 12.0
minincreasingto75% B,from 12.1 to30.0minmaintaining75%
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B, from 30.1 to30.2mindecreasing to 10% B, andfrom30.3 to
45.0 re-equilibrating at 10% B. Thecolumns wereregenerated
regularly with50mLof30% acetonitrile, followedby 200mL
of 100 % acetonitrile, and the guard column cartridges were
replacedperiodically. PeaksofinterestisolatedwiththisHPLC
system were evaporated under N2, redissolved in chloroform,
methanol and water, andextracted. Thechloroformphases were
then dried under N2 and redissolved in the desired solvent.
HPLCAnalysisof[3lHArachidonicAcid
Metabolites
Media wereanalyzedusing apreviouslypublishedHPLC pro-
cedure(15). Justbeforeanalysis, samples werebroughtto room
temperature, mixed(30sec), andcentrifuged at2000gfor6min.
Analiquot(7501sL)ofthesupernatant wastheninjectedintothe
HPLC systememploying an anAlltechUltrasphereODS 5 ,m
reverse-phase column (Rainin Instrument Co., Woburn,MA)
precededby aprecolumnfilter(0.5 jAmfrit; UpchurchScientific,
Oak Harbor, WA). PumpA delivered a water/methanol/acetic
acid(9/1/0.01v/v/v)solution,pH5.05,preparedbytitrationwith
concentratedNH40H: pumpBdelivered 100% methanoltothe
system. Withaflowrateof1.1 mL/minthroughouttherun, agra-
dientelutionwasutilizedwithlinearchangesineluantcomposi-
tion atthe followingtimepoints: 0min, 47% pumpA; 27 min,
40% pumpA; 52min, 27% pumpA; 74min, 0% pumpA; 101
min,re-equilibrationtoinitialconditionsfor 15min. Metabolite
peaks wereidentified aseicosanoidsbasedontheretentiontime
comparedtoexternallyappliedauthenticstandards. Radioactivity
associatedwithpeaks werecorrectedforbaselineradioactivity.
Radioimunnoassay (RIA) ofAA metabolites wasperformed
using kits purchased from either NEN Dupont (Boston, MA),
Amersham (Arlington Heights, IL), or Advanced Magnetics
(Boston, MA).
Thin Layer Chromatography
TLC wasusedtoisolate, quantify, andidentifyPAFaccording
to the method described by Chilton et al. (16). The chromato-
graphy wascarried out onsilicagel60platesthatwereheat ac-
tivated at 120°C for atleast 1 hrbefore use. Samples were spot-
tedunder a streamofwarm airfrom ablowdrier2 cmfromthe
bottomoftheplatein20-50ALofchloroformwith amicroliter
syringe. The plate was reheated at 120°C for 3 min, cooled to
room temperature, and developed towithin 1 cm fromthe top.
Thedevelopmenttank waslinedwith3MMWhatman paperand
equilibratedwith asolventmixconsistingof100mLofchloro-
form, 50mLofmethanol, 16mLofglacialaceticacid, and8mL
of water. After development, the plate was allowed to air dry
under afumehoodandthelipidbands werevisualizedin atank
containing sublimedI2crystals. Forquantificationofradioactive
species, thebands werescrapedintoscintillationvials, 1 mLof
methanol:water 1:1 and3mLofScintiverse LC wereadded, and
the vials were counted for 5 min in a TRI-CARB 1500 Liquid
Scintillation analyzer (Packard, Sterling, VA), with a quench-
correcting program capable ofdiscriminating between 3H and
"4C disintegrations per minute.
Data wereanalyzedusing t-tests forpaired orunpaired vari-
ates. All data are expressed as means ± standard error ofthe
mean.
Resultsand Discussion
Humanalveolarmacrophages wereplatedintotissueculture
dishes and theadherent cells (> 95% plating efficiency) were
incubatedwith 3HJAA for 1-24hr. A4-hrperiodis sufficient
to equilibrate [ H]AA into cellular lipid pools within alveolar
macrophages asassessedby HPLC(Thble 1). There were no ma-
jorchangesinthetritiumassociatedwitheachcellularpoolafter
2 hr of [3H]AA labeling, with the possible exception of the
radioactivity associated with triglycerides, which decreased
fromcontaining29% ofthetritium at 1 hr to 15% at24 hr and
an increase in the combined PE + LPE pool from 5 to 28%.
Phosphatidylcholine wasthemajar reservoirof[3H]AA at 1-16
hr (> 24% atall timepoints sampled).
After incorporation of [3HJAA into cellular pools, human
alveolar macrophages were washed to remove unincorporated
label, 0.5mLphosphate-buffered salinewithglucose (1 mg/mL;
PBS-glucose) wasadded, andthenalveolarmacrophages were
exposed toairor 1.0 ppm03for2hr. Afterexposure, media was
centrifuged and an aliquot counted for radioactivity. Human
alveolarmacrophagesexposed to 03 released 65 ± 12% more
tritium, derived from [3H]AA, thanpairedair-exposedcontrols
into media supernatants (Table 2). Human peripheral blood
monocytes wereprelabeledwith [3H]AA and exposed to 03 in
a similar manner. This cell type had a similar response as the
alveolarmacrophage(Table2). Bothcelltypesremainedviable
throughout the exposures with no difference in viabilities
(> 90% trypan blue exclusion) between 03-exposed and air-
exposedcells. Approximately 10% ofthecellsdetachedduring
eitherair or03 exposure. In a separatestudy, thereappeared to
be a continuous increasein release oftritiuni overthe 2-hr ex-
posureperiodinthe ozone group(1.42 ± 0.39% at 15,min; 2.03
± 0.32% at30min; 3.14 ± 1.21% at 160min; and3.58 ± 1.13%
20min)comparedtotheair-exposedcells. Thevaluesatthe30-
and 120-timepoints weresignificantlyhigherthanthoseobtained
inpairedcultures exposed to airalonefor similartimeperiods
(p< 0.05;n=4-5).
Table 1. Distribution of [3HJarachidonic add in lipid pools with human
alveolarmacrophages.
Timeofin- 3H[AA] distribution inlipidclasses, % total lipid classes
cubationwith PE+ SM + Free
[3HJAA, hr n PC PI LPE LPC PG PS TG AA
1 5 31 12 5 6 5 < 0.2 29 5
2 4 33 14 8 7 1 < 0.2 24 5
4 4 37 14 13 10 1 < 0.2 16 3
16 5 29 12 23 10 0.7 < 0.2 13 3
24 5 24 9 28 8 2 <0.2 15 6
Abbreviations: PC, phosphatidylcholine; PI, phosphatidylinositol; TG,
triglycerides; PG, phosphatidylglycerol; PE, phosphatidylethanolamine; PS,
phosphatidylserine; PA, phosphatidicacid; LPC,lysophosphatidylcholine; SM,
sphingomyelin; AA, arachidonic acid; LPE, lysophosphatidylethanolamine.
Table 2. Effect of03 on the release oftritium by human monocytes and
alveolarmacrophages.'
% 3H released
Exposure, 2 hr Alveolarmacrophages Bloodmonocytes
Air 3.4 ± 0.6 (22) 9.1 ± 3.4 (5)
1.0ppmO3 5.6 ± 1.0*(22) 14.8 ± 5.2*(5)
Tritium derived from cellular [3H]arachidonic acids. Values are means ±
SEM; n inparentheses.
*Significant differencefrom air-exposedvalue,p < 0.05.
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HPLC analysis of media supematants from human O3-ex-
posed alveolar macrophages revealed that the released radio-
activity wasassociatedwith HETEs, freeAA, andthehighest
radioactivity was associated with apolarpeakthateluted with
asimilarretentiontime as03-exposedAA. Thislackofchange
ineicosanoidcontentcomparedto ourpreviouslypublisheddata
in rat macrophages, using similar exposure and separation
methods (17), mayhavebeendue to aninsufflcientnumberof
alveolarmacrophages tosynthesizedetectable AAmetabolites
(< 5 x 10 humanmacrophages wereusedperexposure group
compared to > 5 x 10 rat macrophages used previously),
degradationofformed AA metabolite, or AA itselfinto other
derivatives, and/ormethodological reasons. Therefore, a more
sensitivetechnique, radioimmunoassay, wasusedtodetermine
eicosanoid concentrations in media supernatants of alveolar
macrophages exposed to air or 03. This technique can detect
eicosanoids at approximately 100 pg/mL concentrations.
Human alveolar macrophages were cultured as previously
described, washedto remove serum, 0.5 mLPBS-glucose was
added, andthecells wereexposedtoair or03(O.1-1.Oppmfor
2 hr). After exposure, medium wascollected, centrifuged, and
medium supernatantsanalyzedbyradioimmunoassay (RIA) for
specific metabolites. Theresults areshowninTable3. Alveolar
macrophages exposed to03produced morePGE2thanpaired,
aircontrols in aconcentration-dependent manner, with asignifi-
cant 2.03-fold increase observed in the 1.0-ppm exposed
cultures (p < 0.05). Nodifferences wereobserved inthe for-
mation ofTxB2 or LTB4 between the air-exposed and O3-ex-
posed alveolar macrophages.
To furtherdeterminewhether alterations inAAmetabolism
were presentafter03 exposure, immediatelyafter exposureto
air or 03(0.1-1.0) for2hr, thecells werewashedandthenin-
cubated (at37°C with5% C02) with 1.0mLserum-freeRPMI
containing 10 zM calcium ionophore A23187 (in 0.13%
DMSO) for 30 min. The medium was collected, centrifuged,
and supernatants analyzed by RIA for eicosanoid content.
Results areshown inTable4. Thesedatashowthat03-exposed
¶lble3. Humanalveolarmacrophageeicosanoid productioninresponseto
03exposure (2hr).
03 concen- Eicosanoid synthesis, % airexposure value'
tration, ppm PGE2 TxB2 LTB4
0.1 125 13 (7) 91 8 (7) -
0.3 168 ±22 (9)* 64± 7 (9) -
1.0 203 ± 34 (17)* 69 ± 13 (12) 89 ± 34 (4)
Abbreviations: PGE2, prostaglandin E2; TxB2, thromboxaneB2; LTB4, leu-
kotriene B4.
'Data are shown as means ± SEM; n inparentheses.
*Significant difference frompaired, aircontrol value,p < 0.05.
Table4.Theeffectof03onhumanalveolarncrophageeicosanoidsynthesis
in responsetocalciumionophoreA23187.'
03 concen- Eicosanoid synthesis, % ofairexposure
tration, ppm PGE2 TxB2 LTB4
0.1 164(2) 96 (2) -
0.3 175 (2) 61 (2) 28 (2)
1.0 159 ± 33 (5) 202 ± 119 (5) 96 ± 7 (7)
Abbreviations: PGE2, prostaglandin E2; TxB2, thromboxaneB2; LTB4, leu-
kotriene B4.
'Calcium ionophore, 10,M, 30min. Dataareshownasmeans ± SEM; nin
parentheses.
alveolarmacrophagesstillcouldproduceeicosanoids, similar
toair-exposedculturesinresponsetocalciumionophoreincuba-
tion. Thesedatasuggestthattheobserved03-dependentincrease
inalveolarmacrophagePGE2synthesiswasnotviaacalcium-
dependentmechanism.
OzoneexposurehasbeenshowntoalterAAmetabolisminthe
lung. A 10-fold increasein AA was found inbronchoalveolar
lavage fluid ofrats exposed to 1.1 ppm 03 (24). Seltzer and
associates foundincreased levelsofprostaglandins E2 andF20,
and thromboxane B2 (a product ofthromboxane A2) in bron-
choalveolarlavagefluidofsubjectsexposedto0.4ppm03 for
2hr(2). A2-foldincreaseinprostaglandinE2inthelavagefluid
ofsubjectsexposedto0.4ppmfor2hrwasreportedby Koren
etal. (3). Furtherevidenceofthesignificanceofeicosanoidsin
03toxicity wasprovidedbystudiesreportingprotectionagainst
03-induceddecreasesinfunctionalvolumecapacityandforced
expiratory volume in 1 sec in subjectsadministeredthecyclo-
oxygenaseinhibitorindomethacinbeforeexposureto0.35ppm
03 for 1 hr (18). In vitro studies have also shown AA and
eicosanoid release from lung cells exposed to 03. Bovine en-
dothelial cells exposed to 0.3 ppm 03 for 2 hr were shown to
releaseAA(24), whereasbovineepithelialcellsexposedto0.1
ppm 03 for2 hr released increased amounts ofprostaglandin
F2, (19).
Theeffectofin vitro03exposureoneicosanoidreleasefrom
alveolar macrophages has also been studied. Rabbit alveolar
macrophages released prostaglandin E2 and other cyclooxy-
genaseproducts whenexposed to0.3 and 1.2 ppm03 for2 hr
(20). A3.3-foldincreaseinAAreleasewasfoundinratalveolar
macrophagesexposedto 1.0ppm03for2hr. Theseauthorsalso
foundincreasesinthromboxaneB2andleukotrienesB4, C4, and
D4(17). Thesestudiesindicatethat03canaltertheamountsof
AAmetabolitesbiosynthesizedaswellasincreasethereleaseof
the parent compound, AA. Reports indicating 03-induced
alterations ofAA product formation suggestthatthese altera-
tions areduetomodifications inenzymatic activities (17).
Asreviewed, macrophagescanrespondtoavarietyofstimuli
byproductionofanotherlipidmetabolite, PAF. Theeffectsof
a 2-hr in vitro exposure to human alveolar macrophages,
prelabeledwithprecursor[3H]lysoPAF, areshowninTable5.
Nochangesinviabilitywereseenincellsexposedto 1.0ppm03
compared to air-exposed cells for 60 min. As shown, human
alveolar macrophages obtained from healthy subjects, radio-
labeledandexposedincultureto 1.0ppm0 for60min, hada
1.7-foldsignificantincreaseinthelevelof[ H]PAFcompared
to human alveolar macrophages exposed to air alone (p <
0.002, n = 5). In contrast, human alveolar macrophages in-
cubatedwith 10,uM A23187 for60minhadnonsignificant in-
creasesin[3H]PAFlevels(1.1 O. 01-fold, n = 3)comparedto
vehicle alone.
PAFisderivedfrompreexistingcellularpoolsof1-O-alkyl-
2-arachidonyl-FPC through the action of a phospholipase
Table 5. Effect of ozone exposure (1.0 ppm x 1 hr) on human alveolar
macrophageplatelet-activating factor (PAF) synthesis.'
PAFproduction,dpm x 102 03/air n
91.8 ± 84.8* 1.7 ± 0.2 5
'Theresults areshownas means ± SEMandexpressed as numberofdisin-
tegrationsperminute(dpm) of[3H]PAF in03-exposedcultures. Alldatawere
adjusted for recovery ofa[14C]PAF internal standard.
*Significantdifference from aircontrol values,p < 0.02.
99FRIEDMANETAL.
ITI
PHOSPHATIDYUNOSTOL
(PHOSPHATE.BISPHOSPHATE) PHOSPHATIDYLCHOLINE
ACETPAERASE
LYSOPHOSPHATIDYICHOLINE PAF IP. IP2.
CYCLOOXYGENASE
Ca++ . T LEUJKOTFIENES PHROSTAGLANOE
M IZATION > PKC THROMBOXANE
ACTIVATION PROSTACYCLJN
R 2ELLLAR RErcONS.
FIGURE 2. Schematicdiagram ofcellularlipid interactions.
A2toform 1-0-alkyl-2-lyso-GPC, which isinturnacetylatedby
anacetyltransferase toproducePAF(1-0-alkyl-2-acetyl-GPC).
There isevidence thatthePAFacetyltransferase enzyme canbe
activatedinsomestimulatedcellsthroughabiochemicalmecha-
nism involving protein phosphorylation by serine/threonine
kinases and suggest a role ofprotein kinase C, a Ca -depen-
dent and phospholipid-dependent protein kinase, which is a
pivotal regulatory element in signal transduction. PAF is de-
gradedby PAF-acetylhydrolase, anenzymethatishighly selec-
tiveforphospholipids with shortacylgroupsatthesn-2position
and thus catalyzes the inactivation of PAF by removal of the
acetatemoiety from PAFto formalkyllyso-GPC, whichisbio-
logically inactive. Interestingly, ithasrecentlybeenshownthat
oxidized phospholipids, such as thosethatcould occurincells
after03exposure, aredegradedbythePAFacetylhydrolase (25).
The metabolism and biologic effects ofthese two classes of
lipidmediators, eicosanoidsandPAF,mayalsobeinterrelated.
The release of AA from the sn-2 postion ofphospholipids is
postulatedtobethefirststepintheproductionofcylcooxygenase
andlipoxygenaseproductsaswellasPAF. Alveolarmacrophages
arerich inesterifiedAA, andthe release appears tobecalcium
mediated, including phospholipase A2-mediated deacylation,
phospholipase Caction, andenzymatic processesgoverning for-
mation of diacyl glycerol, cardiolipin, and phosphocholine/
ethanolaminefromphosphatidylcholine(PC)andphosphatidyl-
ethanolamine (PE). However, thereisacomplexpatternofAA
turnover in phospholipids ofalveolar as shown inFigure 2. In
unstimulated cells, AA is predominantly incorporated into PI
and the diacyl species ofPE and PC and then mobilized to the
ether-linked species ofPEand PC. In stimulated cells, several
phospholipid species (primarily phosphoinositides and ether-
andester-linked speciesofPC) serve as sourcesofAA foroxy-
genation intovarious bioactive mediators. Thus, in stimulated
cellsbothphospholipaseA2andphospholipaseCareactivated.
Of the total label lost from PC in response to inflammatory
stimulisuchaslipopolysaccharideoropsonizedzymosan, half
is derived from the I-alkyl-linked species and the rest from 1-
acyl-linked species. Thephospholipase A2 enzyme canhydro-
lyzealkyl-linked PC, providingasubstrateforPAFproduction.
ThephospholipaseCcanactivatephosphoinositidebiphosphate
toproducediacylglyceroland inositolphosphates. These reac-
tionsmayinvolvespecificreceptorsthatlinkG-proteins, protein
kinases, phospholipaseA2andphospholipase C, phosphatidyl-
inositol turnover, cytosolic Ca2, Ca -dependent effectors
such ascalmodulin, diacylglycerol, andmonoglycerollipase, to
theproductionofbioactiveAAmetabolitesandPAR Thus, there
areseveralpotentialmechanismsforthereleaseandsubsequent
metabolism ofAA inalveolar macrophages in response to 03.
Insummary, ourresultsdemonstratethat03exposureresults
in a concentration-dependent release of AA from cell mem-
branes of human alveolar macrophages with subsequent in-
creasedsynthesisofseveralimportantlipidmediatorsincluding
PGE2andPAF. Theselipidmediatorsformedinresponseto03
mayplay animportantroleintheinflammatoryandphysiologic
response of the lung to 03 exposure. Based on the pathways
depicted in Figure 2, these data suggest that 03 may produce
cellularresponsesthroughoneormoreenzymaticpathwaysthat
maybe receptormediated. Futureworkdirected atthecellular
processesregulatingthebiosynthesisandsecretionofpotentlipid
mediators will furthertheunderstanding ofthe response ofthe
lung to inhaled toxicants such as 03.
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